Neuroene Therapeutics
Kensington
About Neuroene Therapeutics
Neuroene Therapeutics is a startup biotechnology company developing novel small molecule mitochondrial therapeutics for epilepsy, Parkinson's Disease, and mitochondrial disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Last round: Grant (Jun 2024)
- Website: neuroenetherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/neuroene-therapeutics-27881 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.